Table 2 Prevalence of P. hominis infections in gastrointestinal cancer and colorectal cancer patients by selected characteristics
From: High prevalence of Pentatrichomonas hominis infection in gastrointestinal cancer patients
Group | Gastrointestinal cancer (n = 195) | Colorectal cancer (n = 116) | ||||||
|---|---|---|---|---|---|---|---|---|
No. examined | No. positive (%) | No. negative (%) | χ2/df/P-value | No. examined | No. positive (%) | No. negative (%) | χ2/df/P-value | |
Age (years) | ||||||||
 ≤ 50 | 44 | 16 (36.36) | 28 (63.64) | 0.97/2/0.62 | 28 | 10 (35.71) | 18 (64.29) | 0.94/2/0.62 |
 51–60 | 61 | 28 (45.9) | 33 (54.1) |  | 31 | 14 (45.16) | 17 (54.84) |  |
 > 60 | 90 | 37 (41.11) | 53 (58.89) |  | 57 | 20 (35.09) | 37 (64.91) |  |
Sex | ||||||||
 Male | 125 | 56 (44.8) | 69 (55.2) | 1.53/1/0.22 | 67 | 25 (37.31) | 42 (62.69) | 0.03/1/0.87 |
 Female | 70 | 25 (35.71) | 45 (64.29) |  | 49 | 19 (38.78) | 30 (61.22) |  |
Residence | ||||||||
 Urban | 113 | 49 (43.4) | 64 (56.6) | 0.37/1/0.54 | 71 | 28 (39.44) | 43 (60.56) | 0.33/1/0.57 |
 Rural | 82 | 32 (39.02) | 50 (60.98) |  | 44 | 15 (34.09) | 29 (65.91) |  |